Fibrocell Science, Inc. Reports Fourth Quarter And Full Year 2013 Financial And Operating Results
Published: Mar 17, 2014
Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today reported financial results for the fourth quarter and full year ended Dec. 31, 2013. The company will host a conference call and webcast at 8:30 a.m. EDT, today.
Help employers find you! Check out all the jobs and post your resume.